Sangamo Therapeutics Inc (SGMO) financials · rev $39.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Sangamo Therapeutics Inc (SGMO) rev $39.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $39.6M | $57.8M |
| Operating Income | -$121.2M | -$104.0M |
| Net Income | -$122.9M | -$97.9M |
| EPS (Diluted) | -$0.44 | -$0.49 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $59.7M | $101.6M |
| Current Assets | $35.8M | $51.7M |
| Cash & Equivalents | $20.9M | $41.9M |
| PP&E | $11.0M | $17.9M |
| Total Liabilities | $74.0M | $78.9M |
| Current Liabilities | $42.5M | $45.8M |
| Shareholders' Equity | -$14.3M | $22.8M |
| Retained Earnings | -$1.63B | -$1.50B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$97.2M | -$67.1M |
| CapEx | $102.0K | $267.0K |
| Investing Cash Flow | -$102.0K | $37.5M |
| Financing Cash Flow | $70.7M | $28.4M |
| Net Change in Cash | -$22.5M | -$3.29M |
| Free Cash Flow | -$97.3M | -$67.4M |
FAQ
What is SGMO P/E and revenue?
Sangamo Therapeutics Inc (SGMO) rev $39.6M.
What is SGMO revenue?
Sangamo Therapeutics Inc last cached revenue is $39.6M (FY2025).
Is SGMO profitable?
Sangamo Therapeutics Inc last cached net income is -$122.9M (FY2025).
What are SGMO total assets?
Sangamo Therapeutics Inc last cached total assets are $59.7M (FY2025).
What is SGMO free cash flow?
Sangamo Therapeutics Inc last cached free cash flow is -$97.3M (FY2025).
Not investment advice. Cached statements, not a live tape.